Suraksha Diagnostic

327.60
-9.65
(-2.86%)
Market Cap
1,706.17 Cr
EPS
4.43
PE Ratio
55.18
Dividend Yield
0.00 %
52 Week High
449.00
52 Week Low
231.00
PB Ratio
8.79
Debt to Equity
0.56
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,829.40
#1 23,651.45
48.50
#1 2,295.80
11.52
#1 362
81.24
55.89
951.00
9,760.71
67.60
568.60
20.11
120
3.56
46.26
1,676.70
8,598.31
59.74
1,216.80
4.59
129
-20.00
51.91
1,026.40
5,439.25
58.55
581.30
8.63
70
25.58
69.55
636.55
2,055.40
26.67
636.40
25.65
57
10.70
35.12
327.60
#6 1,706.17
#6 55.18
#7 222.30
#6 14.77
#7 23
#4 14.29
69.42
1,534.75
1,317.25
33.80
86.70
25.47
32
-9.09
61.89
265.45
844.41
#1 8.58
1,436.10
35.04
6
-1,081.25
60.58
245.45
174.31
14.89
63.00
#1 248.07
7
#1 133.33
41.01
116.40
81.08
61.25
36.90
6.34
1
0.00
47.06

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
14.77 %
Net Income Growth
278.69 %
Cash Flow Change
37.14 %
ROE
231.03 %
ROCE
137.02 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
53
61
53
56
62
68
60
66
Expenses
37
39
37
37
40
44
41
46
EBITDA
16
21
16
20
22
25
19
20
Operating Profit %
28 %
35 %
30 %
34 %
34 %
35 %
31 %
29 %
Depreciation
8
8
8
8
9
9
9
9
Interest
2
3
2
2
2
2
2
2
Profit Before Tax
5
11
6
9
11
14
8
9
Tax
1
3
2
3
3
4
2
2
Net Profit
4
8
5
6
8
10
6
7
EPS in ₹
1.17
2.44
0.87
1.89
1.49
1.94
1.18
1.42

Balance Sheet

Balance Sheet
2023
2024
Total Assets
281
300
Fixed Assets
195
212
Current Assets
68
72
Capital Work in Progress
2
1
Investments
0
0
Other Assets
84
87
Total Liabilities
281
300
Current Liabilities
38
39
Non Current Liabilities
87
82
Total Equity
156
179
Reserve & Surplus
147
171
Share Capital
9
9

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
-0
-1
0
Investing Activities
-20
-28
-44
-21
-35
Operating Activities
31
24
42
44
61
Financing Activities
-10
3
1
-24
-25

Share Holding

% Holding
Jul 2024
Nov 2024
Dec 2024
Mar 2025
Promoter
72.41 %
61.06 %
48.78 %
48.78 %
FIIs
0.00 %
0.00 %
15.39 %
14.46 %
DIIs
0.00 %
0.00 %
20.44 %
22.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.08 %
13.52 %
Others
27.59 %
38.94 %
1.31 %
1.19 %
No of Share Holders
10
10
10
87,275

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 314.65 326.95
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 311.80 347.15
20 Dec 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Dec 2024 411.35 408.00

Announcements

Announcement under Regulation 30 (LODR)-Investor Presentation2 hours ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 hours ago
Compliances-Reg.24(A)-Annual Secretarial Compliance4 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release16 hours ago
Announcement under Regulation 30 (LODR)-Change in Management20 hours ago
Audited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended 31 March 202520 hours ago
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Wednesday 28 May 202520 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20157 days ago
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 27, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 27 March 2025Mar 27, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 07, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 10, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 08, 2025
Integrated Filing (Financial)Feb 08, 2025
Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31 December 2024 Feb 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 08 February 2025Feb 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2024Feb 03, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015- Incorporation Of The Subsidiary Of The CompanyJan 22, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 16, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jan 16, 2025
Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of The CompanyJan 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 06, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptDec 30, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 23, 2024
Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Dec 14, 2024
Resignation Of Mr. Bhaskar Ghoshal, Chief Operating Officer (Senior Management) Of The Company.Dec 12, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Dec 09, 2024
Disclosure Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations)Dec 09, 2024
Closure of Trading WindowDec 06, 2024
Listing of Equity Shares of Suraksha Diagnostic LtdDec 06, 2024

Technical Indicators

RSI(14)
Neutral
69.42
ATR(14)
Less Volatile
11.49
STOCH(9,6)
Overbought
90.37
STOCH RSI(14)
Overbought
86.56
MACD(12,26)
Bullish
2.84
ADX(14)
Weak Trend
22.52
UO(9)
Bearish
71.66
ROC(12)
Uptrend And Accelerating
11.93
WillR(14)
Overbought
-2.77

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Groww ELSS Tax Saver Fund Direct - Growth
19804
1.25%
0.51%
0.97%
Apr 2025
Quant Consumption Fund Direct - Growth
429362
4.53%
0.44%
0.24%
Apr 2025
JM Small Cap Fund Direct - Growth
256705
1.22%
0.43%
0.34%
Apr 2025
Groww Value Fund Direct-Growth
16952
0.99%
0.21%
0.56%
Apr 2025
Quant Healthcare Fund Direct - Growth
340136
2.57%
0.19%
0.00%
Apr 2025
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
239928
0.88%
0.17%
0.10%
Apr 2025
Nippon India Pharma Fund Direct-Growth
3169618
1.15%
0.13%
0.06%
Apr 2025
JM ELSS Tax Saver Fund Direct Plan-Growth
57870
0.92%
0.10%
0.01%
Apr 2025
Bandhan Innovation Fund Direct-Growth
449115
0.94%
0.10%
0.01%
Apr 2025
JM Value Fund Direct Plan-Growth
202145
0.58%
0.09%
0.06%
Apr 2025
Kotak Small Cap Fund Direct-Growth
3043015
0.57%
0.07%
0.05%
Apr 2025
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
1639777
0.33%
0.04%
0.01%
Apr 2025
Groww Multicap Fund Direct-Growth
32916
1.07%
0.04%
0.18%
Apr 2025
Bandhan Balanced Advantage Fund Direct-Growth
249424
0.33%
0.04%
0.02%
Apr 2025
Mirae Asset Healthcare Fund Direct - Growth
0
0.00%
0.00%
-0.06%
Apr 2025
Bandhan BSE Healthcare Index Fund Direct-Growth
193
0.03%
0.00%
0.03%
Apr 2025